• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Erytech Pharma SA

+ Add to Watchlist

ERYP:FP

27.8500 EUR 1.4800 5.61%

As of 04:30:33 ET on 10/24/2014.

Snapshot for Erytech Pharma SA (ERYP)

Open: 26.8000 Day's Range: 26.3700 - 28.7200 Volume: 64,268
Previous Close: 26.3700 52wk Range: 8.5800 - 34.9700 1-Yr Rtn: +184.26%

Stock Chart for ERYP

No chart data available.
  • ERYP:FP 27.8500
  • 1D
  • 1M
  • 1Y
26.3700
Interactive ERYP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ERYP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -0.9890
Est. EPS (EUR) (12/2014) -1.4730
Est. PEG Ratio -
Market Cap (M EUR) 146.79
Shares Outstanding (M) 5.57
30 Day Average Volume 133,914
Price/Book (mrq) 13.9423
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ERYP

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ERYP

Erytech Pharma SA searches and develops biotechnological products. The Company offers therapeutic solutions for treatment of cancer tumors. Erytech Pharma serves patients and medical professionals worldwide.

Gil BeyenChairman/CEOPierre-Olivier GoineauVice Chairman/COO/Co-Founder
Yann GodfrinChief Scientific Ofcr/Co-FounderJerome BaillyDir:Operations
More Company Profile & Key Executives for ERYP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil